Leerink Boosts PT on Alere (ALR) to $56; Doesn't See Regulatory Issues, Stronger Bid Above Abbott (ABT)
Go back to Leerink Boosts PT on Alere (ALR) to $56; Doesn't See Regulatory Issues, Stronger Bid Above Abbott (ABT)| Abbott Laboratories (NYSE: ABT) | Delayed: 102.61 +0.38 (0.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.23 | 52 Week High | $46.38 | |||
| Open | $101.83 | 52 Week Low | $36.00 | |||
| Day High | $103.19 | P/E | 68.41 | |||
| Day Low | $101.50 | EPS | $1.50 | |||
| Volume | 27,075,235 | |||||
| ALERE, Inc. (NASDAQ: ALR) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $54.13 | |||
| Open | $10.12 | 52 Week Low | $31.47 | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-1.13 | |||
| Volume | 7 | |||||
